Bio Impact Capital LLC Harmony Biosciences Holdings, Inc. Transaction History

Bio Impact Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $117,903 - $158,183	2,597 Added 1.9%	139,377 $7.68 Million
Q3 2022 Nov 14, 2022	SELL	$42.06 - $55.45 $30,998 - $40,866	-737 Reduced 0.54%	136,780 $6.06 Million
Q1 2022 May 13, 2022	SELL	$33.14 - $51.13 $163,048 - $251,559	-4,920 Reduced 3.45%	137,517 $6.69 Million
Q4 2021 Feb 11, 2022	SELL	$34.09 - $43.91 $314,071 - $404,542	-9,213 Reduced 6.08%	142,437 $6.07 Million
Q3 2021 Nov 15, 2021	BUY	$25.68 - $38.61 $3.89 Million - $5.86 Million	151,650 New	151,650 $5.81 Million

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bio Impact Capital LLC with notifications on news.